Ovid Therapeutics Sector: Rare disease, small molecule therapeutics for neurological disorders HQ: Hudson Commons building at 441 Ninth Avenue, New York, NY Year Founded: 2014 Key Leaders: Jeremy Levin, DPhil, MB BChir, CEO and Chairman Number of Employees: 11-50 Stage: Public Financial Snapshot: $105.95 million market cap Notable Investors: Takeda Pharmaceutical Co
Many people, however, are exposed to larger quantities of this smelly gas, quantities that are more toxic than beneficial (Blachier et al., 2007
Lecithin, a component found in animal and plant cells, accelerates the breakdown and removal of fat cells
Both medications help reduce appetite, and we customize treatment plans to suit your unique needs for optimal weight management outcomes